Home Featured 2

Featured 2

Featured posts

Most popular

Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung Cancer

lungcanc

Rebuilding Choice Architecture for Incurable but Treatable Lung Cancer: Rethinking the Future of Hospice Care in the United States

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

NCI Director Dr. Norman E. Sharpless Discusses 2019 Budget Plans During Social Media Event

Doctor of Nursing Practice Project Aims to Educate Non-Oncology Providers About the Management of Immunotherapy AEs

Making Headway with Lorlatinib

lungcanc

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

lungcanc

Lung Cancer Pathology Pioneer Dr. Adi Gazdar Dies at 81

lungcanc

PD-L1 in Cytology Specimens

lungcanc

Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data

lungcanc

PACIFIC Flooded Us with Optimism. Now What?

lungcanc

U.S. Drug Approvals: 2010 – 2020

lungcanc

Korean Lung Cancer Screening Project (K-LUCAS) Led to Launch of New...

lungcanc

Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A...

lungcanc

The Changing the Landscape of Tobacco Products: Potential Effects of ENDS...

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib